MedPageToday
MedPage Today) — LONG BEACH, Calif. — Outcomes in neovascular age-related macular degeneration (nAMD) failed to improve with the addition of a multitargeted trap fusion protein to anti-VEGF therapy, according to a randomized trial reported…
Read More
Combination Therapy for AMD Fails to Improve Vision Versus Single Drug
Georgianna Michaud
06:19
MedPage Today) — LONG BEACH, Calif. — Outcomes in neovascular age-related macular degeneration (nAMD) failed to improve with the addition of a multitargeted trap fusion protein to anti-VEGF therapy, according to a randomized trial reported…
